Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal Response

Currently available Neisseria meningitidis serogroup B (MenB) vaccines are based on outer membrane vesicles (OMVs) that are obtained from wild-type strains. They are purified with the aim of decreasing the lipooligosaccharide (LOS) content and hence reduce the reactogenicity of the vaccine even thou...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Weynants, V., Denoël, P., Devos, N., Janssens, D., Feron, C., Goraj, K., Momin, P., Monnom, D., Tans, C., Vandercammen, A., Wauters, F., Poolman, Jan T.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology (ASM) 2009
Gaiak:
Microbial Immunity and Vaccines
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2681751/
https://ncbi.nlm.nih.gov/pubmed/19289516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.01108-08
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak